Topchoice Medical Co., Inc. (SHA:600763)
China · Delayed Price · Currency is CNY 34.66
-0.14 (-0.40%)
Jun 18, 2026, 3:00 PM CST
Topchoice Medical Co. Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Topchoice Medical Co. stock has a consensus rating of "Hold" and an average price target of ¥44.76. The average 1-year stock price forecast is 29.14% higher than the current stock price, while the lowest is ¥30.00 (-13.44%) and the highest is ¥55.88 (+61.22%).
Price Target: ¥44.76 (+29.14%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Topchoice Medical Co. stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 3 | 4 | 4 | 4 | 3 | 3 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 2 | 2 |
| Total | 9 | 8 | 8 | 8 | 8 | 10 |
Financial Forecast
Revenue This Year
3.24B
from 2.91B
Increased by 11.23%
Revenue Next Year
3.54B
from 3.24B
Increased by 9.35%
EPS This Year
1.33
from 1.11
Increased by 19.82%
EPS Next Year
1.51
from 1.33
Increased by 13.53%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.5B | ||
| Avg | 3.2B | ||
| Low | 3.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 20.9% | ||
| Avg | 11.2% | ||
| Low | 3.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 1.33 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 19.8% | ||
| Low | - |